2025
SJR Q2
JCR Q3 · 2,1
OA
3 matched articles
ESCI
Journal detail
CVIR Endovascular
- Publisher
- Springer Science and Business Media Deutschland GmbH
- Country
- Switzerland · Western Europe
- Type
- journal
- ISSN
-
25208934
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,489
- Quartile Q2
- H-Index 20
- Cites/doc 1,99
- Docs (3y) 219
- Cites (3y) 404
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2,1
- 5Y JIF 1,7
- JCI 0,43
WoS indexes
- ESCI
Subject classification
Categories (SJR)
- Cardiology and Cardiovascular Medicine Q3
- Radiology, Nuclear Medicine and Imaging Q2
Areas
- Medicine
WoS categories
- Cardiac & Cardiovascular System | Radiology, Nuclear Medicine & Medical Imaging | Peripheral Vascular Diseases
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,489 | 2,1 | 1,7 | 0,43 | Q3 | 20 |
| 2024 | Q3 | Q3 | 0,434 | 1,5 | 1,5 | 0,37 | Q3 | 16 |
| 2023 | Q3 | Q3 | 0,36 | 1,2 | 1,4 | 0,3 | Q4 | 16 |
| 2022 | Q3 | — | 0,326 | 1,2 | 1,3 | 0,28 | Q4 | 16 |
| 2021 | Q4 | — | 0,202 | — | — | 0,26 | Q4 | 16 |
| 2020 | — | — | — | — | — | — | — | 16 |
| 2019 | — | — | — | — | — | — | — | 16 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | CARDIAC & CARDIOVASCULAR SYSTEMS | ESCI | Q3 | Q3 | 138/237 |
| 2025 | PERIPHERAL VASCULAR DISEASE | ESCI | Q3 | Q3 | 57/100 |
| 2025 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | ESCI | Q3 | Q3 | 114/217 |
| 2024 | CARDIAC & CARDIOVASCULAR SYSTEMS | ESCI | Q3 | Q3 | 149/231 |
| 2024 | PERIPHERAL VASCULAR DISEASE | ESCI | Q3 | Q4 | 73/98 |
| 2024 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | ESCI | Q3 | Q3 | 137/213 |
| 2023 | CARDIAC & CARDIOVASCULAR SYSTEMS | ESCI | Q4 | Q4 | 167/222 |
| 2023 | PERIPHERAL VASCULAR DISEASE | ESCI | Q4 | Q4 | 77/96 |
| 2023 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | ESCI | Q3 | Q4 | 149/204 |
| 2022 | CARDIAC & CARDIOVASCULAR SYSTEMS | ESCI | — | Q4 | — |
| 2022 | PERIPHERAL VASCULAR DISEASE | ESCI | — | Q4 | — |
| 2022 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | ESCI | — | Q4 | — |
| 2021 | CARDIAC & CARDIOVASCULAR SYSTEMS | ESCI | — | Q4 | — |
| 2021 | PERIPHERAL VASCULAR DISEASE | ESCI | — | Q4 | — |
| 2021 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | ESCI | — | Q4 | — |